5 Preclinical Studies Of Innovative Medicines, Federal Target Program Development Of The Pharmaceutical And Medical Industry Of The Russian Federation Until 2020 And Beyond Perspective, (VIII Ochered_3) On The Theme: Preclinical Studies Of Antiarrhythmic Drug
Based Alkaloid Lappaconitine
Various therapeutic options are available to treat patients with AF, and most patients will receive some form of antithrombotic therapy, a heart rate control agent, and potentially, an antiarrhythmic drug
for rhythm control.
Amiodarone is a class III antiarrhythmic drug
widely used for the treatment of supraventricular and ventricular tachyarrhythmias and in the management of severe congestive heart failure.
The authors conducted a prospective study of the efficacy of sequential antiarrhythmic drug
therapy in SR maintenance after a successful ECV in individuals with chronic AF.
The antiarrhythmic drug
amiodarone is associated with an increased risk of cancer, but the effect is significant only in men or at higher doses, according to a Taiwanese population-based cohort study.
Multiple ectopic beats that are causing palpitations, or that occur after a myocardial infarction, can be treated with an antiarrhythmic drug
For patients with low risk, dronedarone provides the only antiarrhythmic drug
with a large safety database to prove reasonable safety," he added.
Amiodarone, an antiarrhythmic drug
approved for controlling life-threatening recurrent ventricular arrhythmias, is marketed as Cordarone and Pacerone.
Several randomized trials, largely in patients with coronary artery disease and left ventricular dysfunction or in patients with documented lethal arrhythmias, showed beyond doubt that the ICD is superior to antiarrhythmic drug
therapy in preventing sudden death, although a number of trials showed no effect.
The purpose of the meeting was to discuss the appropriate regulatory pathway for filing a marketing application of ATPace(TM) as an antiarrhythmic drug
for the acute termination of paroxysmal supraventricular tachycardia (PSVT).
Randomized comparison of antiarrhythmic drug
therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH).
Similarly, gene screening will allow antiarrhythmic drug
treatment to begin before a cardiac event occurs.